Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank77
3Y CAGR-32.5%
Studio
Year-over-Year Change

Year-over-year net income growth rate

3Y CAGR
-32.5%/yr
Annual compound
Percentile
P77
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202430.39%
2023-41.90%
2022-18122.02%
202198.81%
202073.63%
2019-219.06%
2018-16.07%
2017-1635.11%
2016105.65%
20153.13%